Showing results (31-40 of 329) with videos related to
Sort By:
Pageof 33
Current Treatment Options in Oncology|April 18, 2018
Current Status of Neoadjuvant Endocrine Therapy in Early Stage Breast CancerTomás Reinert, Rodrigo Gonçalves, Matthew J EllisGan to Kagaku Ryoho. Cancer & Chemotherapy|June 23, 2009
[Future prospects of neoadjuvant endocrine therapy in postmenopausal breast cancer]Masakazu Toi, Hironobu Sasano, Matthew J EllisClinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 7, 2019
CDK4/6 Inhibitor Biomarker Research: Are We Barking Up the Wrong Tree?Meenakshi Anurag, Svasti Haricharan, Matthew J EllisCancer|October 31, 2002
An overview of the pharmacology and pharmacokinetics of the newer generation aromatase inhibitors anastrozole, letrozole, and exemestaneAman U Buzdar, John F R Robertson, Wolfgang Eiermann, et al.Molecular & Cellular Oncology|December 8, 2018
ESR1 fusions drive endocrine therapy resistance and metastasis in breast cancerJonathan T Lei, Xuxu Gou, Matthew J EllisInternational Journal of Breast Cancer|February 2, 2012
Molecular basis of triple negative breast cancer and implications for therapyParvin F Peddi, Matthew J Ellis, Cynthia MaBreast Disease|July 23, 2011
Molecular profiling of triple negative breast cancerCynthia X Ma, Jingqin Luo, Matthew J EllisNature Reviews. Clinical Oncology|December 7, 2011
Practical implications of gene-expression-based assays for breast oncologistsAleix Prat, Matthew J Ellis, Charles M PerouAdvances in Experimental Medicine and Biology|March 19, 2016
Prognostic and Predictive Biomarkers of Endocrine Responsiveness for Estrogen Receptor Positive Breast CancerCynthia X Ma, Ron Bose, Matthew J EllisEuropean Journal of Cancer (Oxford, England : 1990)|January 8, 2021
Meta-analyses of phase 3 randomised controlled trials of third generation aromatase inhibitors versus tamoxifen as first-line endocrine therapy in postmenopausal women with hormone receptor-positive advanced breast cancerJohn F R Robertson, Robert J Paridaens, Jasmine Lichfield, et al.Pageof 33